• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Absence of drying effect makes epinastine a treatment consideration in patients with dry eye

Article

Epinastine HCl 0.05% does not have a drying effect on the ocular surface and may be kinder to patients being treated for seasonal allergies and underlying dry eye disease.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Edward Manche, MD
Related Content
Keratoconus in a pediatric population has higher prevalence than expected

Keratoconus in a pediatric population has higher prevalence than expected

Article
ROP: Treating and preventing blindness in preterm babies

ROP: Treating and preventing blindness in preterm babies

Podcast
Partners collaborate on integration of AI-supported ROP telemedicine globally

Partners collaborate on integration of AI-supported ROP telemedicine globally

Article
Managing a changing landscape of IRD pediatric cases

Managing a changing landscape of IRD pediatric cases

Podcast
An approach to preventing progression of pediatric myopia

An approach to preventing progression of pediatric myopia

Article
AAO 2023: Phase III CHAMP and more trials pioneering myopia management in children

AAO 2023: Phase III CHAMP and more trials pioneering myopia management in children

Article
© 2024 MJH Life Sciences

All rights reserved.